Cambiar Investors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,621
Closed -$1.4M 154
2026
Q1
$1.4M Sell
18,621
-3,000
-14% -$246K 0.06% 119
2025
Q4
$1.69M Hold
21,621
0.08% 105
2025
Q3
$1.84M Buy
21,621
+1,118
+5% +$89.6K 0.08% 103
2025
Q2
$1.6M Sell
20,503
-12
-0.1% -$885 0.07% 113
2025
Q1
$1.48M Sell
20,515
-4,035
-16% -$339K 0.06% 119
2024
Q4
$2.18M Sell
24,550
-2,105
-8% -$188K 0.09% 112
2024
Q3
$2.26M Buy
26,655
+6,350
+31% +$563K 0.09% 113
2024
Q2
$1.88M Hold
20,305
0.07% 125
2024
Q1
$2.29M Sell
20,305
-498
-2% -$49.7K 0.09% 116
2023
Q4
$1.94M Hold
20,803
0.08% 136
2023
Q3
$1.91M Buy
20,803
+1,900
+10% +$204K 0.08% 132
2023
Q2
$2.29M Sell
18,903
-6,641
-26% -$716K 0.1% 109
2023
Q1
$2.5M Sell
25,544
-136
-0.5% -$13K 0.11% 110
2022
Q4
$2.08M Buy
25,680
+6,025
+31% +$505K 0.09% 124
2022
Q3
$1.49M Buy
19,655
+3,179
+19% +$306K 0.08% 117
2022
Q2
$1.8M Sell
16,476
-10,580
-39% -$1.12M 0.08% 104
2022
Q1
$2.69M Buy
27,056
+1,591
+6% +$152K 0.1% 100
2021
Q4
$2.43M Buy
+25,465
New +$2.55M 0.08% 125

Other funds holding USPH

Cambiar Investors's USPH Position: Q2 2026 in Review

Cambiar Investors sold out of US Physical Therapy (USPH) in Q2 2026, closing a stake of 18,621 shares — an estimated $1.4M sold.

Cambiar Investors first reported a position in USPH in Q4 2021 and held it in 18 quarters. The position peaked at $2.69M in Q1 2022. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Cambiar Investors reported no remaining US Physical Therapy position as of Q2 2026 after selling out during the quarter.
  • Cambiar Investors sold 18,621 US Physical Therapy shares in Q2 2026, an estimated $1.4M.
  • Cambiar Investors first reported a position in US Physical Therapy in Q4 2021 and held it in 18 quarters.
  • Cambiar Investors's US Physical Therapy position peaked at $2.69M in Q1 2022.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.